No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

hear.com Unveils Next-Gen Addition to Horizon AX Hearing Aid Line

Editor: What To Know

  • Com’s Clinic-in-a-Box™ Tele-Audiology journey delivers a package including a tablet, hearing aids, and all diagnostic equipment needed to conduct a high-quality medical hearing evaluation and fitting of hearing devices, right to your doorstep, and is proven to deliver superior outcomes versus in-clinic fittings.
  • 5 billion people are projected to have some degree of hearing loss globally by 2050, yet there is a gap in hearing care driven by both limited affordability and access to quality devices, along with the perceived stigma of hearing aids.
  • Speech Focus Mode provides an extra boost of crystal-clear speech comprehension by identifying and suppressing background noise in real time – allowing the user to focus on one-on-one conversations even in noisy environments like restaurants, sporting events, conferences, etc.

hear.com, the world’s largest online provider of expert, medical-grade hearing care, today announced the launch of its new hearing aid line, the Horizon AX, enhancing its already robust product portfolio. In support of hear.com’s mission to bring high-quality hearing care to anyone, anywhere, the new family of hearing aids are for those seeking an affordable, easy-to-use solution that provides the most advanced sound experience possible.

Nearly 2.5 billion people are projected to have some degree of hearing loss globally by 2050, yet there is a gap in hearing care driven by both limited affordability and access to quality devices, along with the perceived stigma of hearing aids. When combined with hear.com’s two-tier case management approach, the new Horizon AX line goes a long way toward addressing the root causes of subpar hearing care and acceptability. The hear.com Horizon AX hearing aid line boasts an elite, revolutionary sound experience not found in any other hearing devices on the market today. The stylish design offers discrete placement and provides users with excellent speech understanding, built-in situation detection technology, and bespoke features specifically for the more active user, including:

  • Speech Focus Mode provides an extra boost of crystal-clear speech comprehension by identifying and suppressing background noise in real time – allowing the user to focus on one-on-one conversations even in noisy environments like restaurants, sporting events, conferences, etc.
  • Panorama Mode boosts sound clarity in a 360-degree radius around the user, ensuring clear and realistic comprehension from every direction.
  • Relax Mode mutes microphones at the touch of a button and emits serene, stress-relieving ocean sounds.

Horizon AX products also make it possible to clear speech understanding, combining the most innovative technology with the experience of over three million customer consultations. Using two separate processors, this state-of-the-art technology significantly increases the contrast between speech and background noise, making speech more easily understandable and accentuating frequencies at the user’s fingertips.

“The best hearing aid we’ve ever sold,” hear.com’s Horizon AX seamlessly connects users to the world. All devices come with Bluetooth connection, rechargeable batteries, and direct integration with both Apple iPhone and Android products. The Horizon smartphone app for simple, discreet hearing care management allows users to access music, telephone calls, podcasts and even TV with the Streamline TV feature.

Featuring three unique styles – the Style, Go and Mini – the Horizon AX line is designed to offer cutting-edge technology without compromising style or comfort. The line is available in multiple colors with a sleek behind-the-ear style and will be available as  in-the-canal hearing aids later this year.

The hear.com Horizon AX is available to be fit today either via a hand-selected hear.com partner audiologist or the company’s Tele-Audiology option. hear.com’s Clinic-in-a-Box™ Tele-Audiology journey delivers a package including a tablet, hearing aids, and all diagnostic equipment needed to conduct a high-quality medical hearing evaluation and fitting of hearing devices, right to your doorstep, and is proven to deliver superior outcomes versus in-clinic fittings.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy